Search - tctmd.com

Displaying 1 - 20 of 328

Sort: Relevancy | Date

Presentation ESC 2025

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

Presenter: Mohamed Abdel-Wahab

August 29, 2025

Presentation TCT India 2025

Transcatheter Mitral Valve Replacement (TMVR): Left Ventricular Outflow Tract (LVOT) Obstruction

Presenter: Samir Kapadia

July 27, 2025

Presentation ACC 2025

Dapagliflozin after Transcatheter Aortic Valve Implantation

Presenter: Sergio Raposeiras-Roubin

March 29, 2025

Presentation Miami Valves 2025

Transcatheter treatment of Aortic Regurgitation

Presenter: Venkatesh Alapati

January 30, 2025

Presentation ESC 2024

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Presenter: Jacob Lønborg

August 31, 2024

Presentation EuroPCR 2024

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Presenter: Eliano Navarese

May 15, 2024

Presentation EuroPCR 2024

Long-term multiple comparison of transcatheter aortic valves – insights from the OBSERVANT II study

Presenter: Giuliano Costa

May 14, 2024

Presentation THT Abstracts 2024

Appreciating the immediate changes in left ventricular cardiomechanics after transcatheter aortic valve replacement for moderate aortic stenosis: a case series

Presenter: Antoon van den Enden

March 05, 2024

Presentation Cardiovascular Interventions 2023

Transcatheter Valve Technology: Where Are We Now?

Presenter: Curtiss T. Stinis

November 10, 2023

Presentation Complex Coronary Cases 2023

Updates on Transcatheter Structural Heart Interventions

Presenter: Hyo Jin Kang

June 16, 2023

Presentation ACC 2023

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Presenter: John K. Forrest

March 05, 2023

Presentation ARCH 2022

Transcatheter Aortic Valve Replacement for LVAD-related AI

Presenter: Jeffrey Sparling

April 23, 2022

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

Presentation TCT 2020

SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve

Presenter: Thomas Walther

October 17, 2020

A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation: 1-year Results

Presentation TCT 2020

SOLVE TAV - A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation: 1-year Results

Presenter: Hans-Josef Feistritzer

October 16, 2020

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

Presentation TVT 2020

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

Presenter: Hasan Jilaihawi

June 21, 2020

Presentation TVT 2020

Outcomes of Surgical Explantation of TAVR– A Population-Based, Nationally-Representative Analysis

Presenter: Tsuyoshi Kaneko

June 21, 2020

Advertisement

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

Transcatheter Mitral Valve Replacement (TMVR): Left Ventricular Outflow Tract (LVOT) Obstruction

Dapagliflozin after Transcatheter Aortic Valve Implantation

Transcatheter treatment of Aortic Regurgitation

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Long-term multiple comparison of transcatheter aortic valves – insights from the OBSERVANT II study

Appreciating the immediate changes in left ventricular cardiomechanics after transcatheter aortic valve replacement for moderate aortic stenosis: a case series

Transcatheter Valve Technology: Where Are We Now?

Updates on Transcatheter Structural Heart Interventions

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Transcatheter Aortic Valve Replacement for LVAD-related AI

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve

SOLVE TAV - A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation: 1-year Results

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

Outcomes of Surgical Explantation of TAVR– A Population-Based, Nationally-Representative Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content